Increased IL-6 Levels Inhibites by Zinc and Melatonin Support in Rats with Breast Cancer induced by DMBA

The aim of the present study determines the effect of zinc and melatonin supplementation on IL-6 levels in female rats with breast cancer induced by DMBA (7,12-Dimethylbenz[a]anthracene). Total 42 wistar female rats which was just weaned from milk equally separated 5 groups. Group 1 control, Group 2 DMBA control, Group 3 DMBA+Zinc, Group 4 DMBA+Melatonin, Group 5 DMBA+Zinc+Melatonin. To induce breast cancer, the animals, except those in group 1, were administered 80 mg/kg of DMBA in colza oil (canola) through gavage. The groups which were supplemented with zinc and melatonin were introperitoneally given 5 mg/kg/day of zinc, melatonin and zinc+melatonin for 4 weeks. Blood samples were taken under general anesthesia to tube with EDTA, and IL-6 levels were determined by ELISA. The highest IL-6 levels were determined in the DMDA control group (p<0.05). DMBA + zinc and DMBA+ melatonin groups were had lower IL-6 levels compared to group 2 (p<0.05). Group 5 has the lowest IL-6 levels compared to all breast cancer induced groups (G 2,3,4) (p<0.05). The results of the present study indicate that increased IL-6 levels in breast cancer inhibites by zinc and melatonin. However, the most significant inhibition was seen in combine of zinc and melatonin (group 5). The combined administration of zinc + melatonin may contribute to the prevention of tumoral growth by suppressing IL-6 levels, which can accelerate cancer development.

Erişime Açık
Görüntülenme
14
22.03.2024 tarihinden bu yana
İndirme
1
22.03.2024 tarihinden bu yana
Son Erişim Tarihi
22 Haziran 2024 04:46
Google Kontrol
Tıklayınız
Tam Metin
Tam Metin İndirmek için tıklayın Ön izleme
Detaylı Görünüm
Eser Adı
(dc.title)
Increased IL-6 Levels Inhibites by Zinc and Melatonin Support in Rats with Breast Cancer induced by DMBA
Yayın Türü
(dc.type)
Konferans Bildirisi
Yazar/lar
(dc.contributor.author)
BALTACI, Saltuk Buğra
Yazar/lar
(dc.contributor.author)
GÜLBAHÇE MUTLU, Elif
Yazar/lar
(dc.contributor.author)
MOĞULKOÇ, Rasim
Yazar/lar
(dc.contributor.author)
BALTACI, Abdülkerim Kasım
Atıf Dizini
(dc.source.database)
Diğer
Konu Başlıkları
(dc.subject)
DMBA
Konu Başlıkları
(dc.subject)
Breast Cancer
Konu Başlıkları
(dc.subject)
IL-6
Konu Başlıkları
(dc.subject)
Zinc
Konu Başlıkları
(dc.subject)
Melatonin
Yayıncı
(dc.publisher)
Internatıonal Academic Research Congress (INES-2018)
Yayın Tarihi
(dc.date.issued)
2018
Kayıt Giriş Tarihi
(dc.date.accessioned)
2019-07-10T08:50:43Z
Açık Erişim tarihi
(dc.date.available)
2019-07-10T08:50:43Z
Özet
(dc.description.abstract)
The aim of the present study determines the effect of zinc and melatonin supplementation on IL-6 levels in female rats with breast cancer induced by DMBA (7,12-Dimethylbenz[a]anthracene). Total 42 wistar female rats which was just weaned from milk equally separated 5 groups. Group 1 control, Group 2 DMBA control, Group 3 DMBA+Zinc, Group 4 DMBA+Melatonin, Group 5 DMBA+Zinc+Melatonin. To induce breast cancer, the animals, except those in group 1, were administered 80 mg/kg of DMBA in colza oil (canola) through gavage. The groups which were supplemented with zinc and melatonin were introperitoneally given 5 mg/kg/day of zinc, melatonin and zinc+melatonin for 4 weeks. Blood samples were taken under general anesthesia to tube with EDTA, and IL-6 levels were determined by ELISA. The highest IL-6 levels were determined in the DMDA control group (p<0.05). DMBA + zinc and DMBA+ melatonin groups were had lower IL-6 levels compared to group 2 (p<0.05). Group 5 has the lowest IL-6 levels compared to all breast cancer induced groups (G 2,3,4) (p<0.05). The results of the present study indicate that increased IL-6 levels in breast cancer inhibites by zinc and melatonin. However, the most significant inhibition was seen in combine of zinc and melatonin (group 5). The combined administration of zinc + melatonin may contribute to the prevention of tumoral growth by suppressing IL-6 levels, which can accelerate cancer development.
Yayın Dili
(dc.language.iso)
en
Tek Biçim Adres
(dc.identifier.uri)
https://hdl.handle.net/20.500.12498/1076
Analizler
Yayın Görüntülenme
Yayın Görüntülenme
Erişilen ülkeler
Erişilen şehirler
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms